Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

28 May 2016
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

Shamberg Johnson Bergman wins pain clinic case in Kansas

KANSAS CITY, Missouri, May 28, 2016 /PRNewswire/ -- Today, the Kansas Court of Appeals affirmed in its entirety the $2.88 million verdict obtained in April 2014 in Johnson County, Kan., by SJB attorneys Scott Nutter, John Parisi and Daniel Singer on behalf of Vernon and Gail Burnette against... Read more ››

By: PR Newswire Association LLC. - 28 May 2016

Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA(TM) (daclizumab) for Multiple Sclerosis

CAMBRIDGE, Mass. and NORTH CHICAGO, Ill., May 27, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved ZINBRYTA(TM) (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS), Read more ››

By: PR Newswire Association LLC. - 28 May 2016
Related companies:  Biogen | AbbVie Inc.

4°C Blood Bank Refrigerators Industry Global Market Research Report 2016

PUNE, India, May 27, 2016 /PRNewswire-iReach/ -- ACCESS REPORT @ Global 4°C Blood Bank Refrigerators Industry 2016 Market Research Report

... Read more ››
By: PR Newswire Association LLC. - 28 May 2016

Breast Implants Consumption Global Market Research Report 2016

PUNE, India, May 27, 2016 /PRNewswire-iReach/ -- ACCESS REPORT @ Global Breast Implants Consumption 2016 Market Research Report

Read more ››
By: PR Newswire Association LLC. - 28 May 2016

Semaglutide Demonstrated Superior Glycaemic Control vs Insulin Glargine U100 in Adults with Type 2 Diabetes

ORLANDO, Fla., May 28, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 28 May 2016
Related companies:  Novo Nordisk Inc.

Semaglutide Demonstrated Superior Glycemic Control vs Insulin Glargine U100 in Adults with Type 2 Diabetes

ORLANDO, Fla., May 27, 2016 /PRNewswire/ -- Findings from a phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide, administered once-weekly, significantly improved glycemic control compared to insulin... Read more ››

By: PR Newswire Association LLC. - 28 May 2016
Related companies:  Novo Nordisk Inc.

CMS Opens CPC+ to 1,500 ACO Participants

BEAVERTON, Ore., May 27, 2016 /PRNewswire/ -- The Centers for Medicare and Medicaid Services (CMS) announced today the opportunity for up to 1,500 eligible primary care practices currently in the Medicare Shared Savings Program (MSSP) to also participate in Comprehensive Primary Care Plus (CPC+),... Read more ››

By: PR Newswire Association LLC. - 28 May 2016

Current Pharmaceutical Industry Trends in Medical Education are Highlighted in New Study

CHAPEL HILL, N.C., May 27, 2016 /PRNewswire/ -- Medical education plays an essential role in updating physicians and other health care professionals about a pharmaceutical company's latest medical knowledge.

Read more ››
By: PR Newswire Association LLC. - 28 May 2016

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

Read more ››
By: Nasdaq / GlobenewsWire - 27 May 2016
Related companies:  Bavarian Nordic A/S

Oxazepam Market Trends and 2021 Forecasts for Manufacturers

NEW YORK, May 27, 2016 /PRNewswire-iReach/ -- 2016 Oxazepam Industry Report - Global and Chinese Market Scenario offer a detailed market survey and an in-depth study of the overall Oxazepam industry. The report comprehends of all major aspect of the industry, from top player's company profile... Read more ››

By: PR Newswire Association LLC. - 27 May 2016

Mouth Ulcer Treatment Drug Industry United States Market Research Report 2016

PUNE, India, May 27, 2016 /PRNewswire-iReach/ -- ACCESS REPORT @ United States Mouth Ulcer Treatment Drug Industry 2016 Market Research... Read more ››

By: PR Newswire Association LLC. - 27 May 2016

Orexigen Announces Upcoming Presentations at European Obesity Summit 2016

SAN DIEGO, May 27, 2016 /PRNewswire/ -- Orexigen Therapeutics (NASDAQ: OREX) announced today six poster presentations, including two selected as poster pitch sessions, on naltrexone HCl / bupropion HCl, marketed as Contrave® in the United States and Mysimba® in the European Union, at the European... Read more ››

By: PR Newswire Association LLC. - 27 May 2016
Related companies:  Orexigen Therapeutics, Inc.

In-Vitro Diagnostic Testing Services Market 2016 Asia-Pacific Trends and Forecasts to 2019  - Research and Markets

DUBLIN, May 27, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 May 2016
Related companies:  Ascendiant Capital Markets LLC | Wombat Capital Markets SAS | Aberdeen Gould Capital Markets Ltd. | Research On Global Markets

European In-Vitro Diagnostic Testing Services Market Trends and Forecasts Report 2016-2019 - Research and Markets

DUBLIN, May 27, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 May 2016
Related companies:  Ascendiant Capital Markets LLC | Wombat Capital Markets SAS | Aberdeen Gould Capital Markets Ltd. | Research On Global Markets

China Blood Testing (Typing, Immunoassay, NAT Testing) Market Overview 2016-2020 - Research and Markets

DUBLIN, May 27, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 May 2016
Related companies:  Ascendiant Capital Markets LLC | Wombat Capital Markets SAS | Aberdeen Gould Capital Markets Ltd. | Research On Global Markets

Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market to 2019 - Research and Markets

DUBLIN, May 27, 2016 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 May 2016
Related companies:  Ascendiant Capital Markets LLC | Wombat Capital Markets SAS | Aberdeen Gould Capital Markets Ltd. | Research On Global Markets

M    Orthopedics Receives $750,000 "Accelerator Loan" from the Massachusetts Life Sciences Center

LEXINGTON, Mass., May 27, 2016 /PRNewswire/ -- M Orthopedics Corp. (M O) of Lexington, Massachusetts is proud to announce that the company has been awarded a $750,000 "Accelerator Loan" from the Massachusetts Life Sciences Center (MLSC). The Accelerator Loan - awarded on a competitive basis... Read more ››

By: PR Newswire Association LLC. - 27 May 2016

RegeneRx Comments on Valuation

ROCKVILLE, Md., May 27, 2016 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, made the following comments today on its stock price:

Read more ››
By: PR Newswire Association LLC. - 27 May 2016
Related companies:  Regenerx

Teamster Pharmacists: Jewel-Osco's Business Decisions Put Public At Risk

CHICAGO, May 27, 2016 /PRNewswire-USNewswire/ -- Teamsters Local 727 began informing the public of the safety risks associated with Jewel-Osco's chronic understaffing of pharmacies amid ever-increasing pharmacist workloads by informational picketing outside Chicago-area Jewel-Osco stores this... Read more ››

By: PR Newswire Association LLC. - 27 May 2016

CVS Health To Present At The Goldman Sachs 37th Annual Global Healthcare Conference

WOONSOCKET, R.I., May 27, 2016 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that Dave Denton, executive vice president and chief financial officer, will be speaking to investors at the Goldman Sachs 37(th) Annual Global Healthcare Conference on June 8, 2016, at approximately... Read more ››

By: PR Newswire Association LLC. - 27 May 2016
Related companies:  CVS Health Corporation
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next